Bipolar disorder and crossover design

A randomised, double-blind, placebo-controlled crossover trial on cannabinoid-based medication for behavioural disorders in old patients with severe dementia: the study results.

Age and ageing·2026

Antiviral Use in Mild-to-Moderate SARS-CoV-2 Infections during the Omicron Wave in Geriatric Patients.

Viruses·2024

Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol.

Pharmaceuticals (Basel, Switzerland)·2023

Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocol.

Frontiers in pain research (Lausanne, Switzerland)·2023

Is massage a legitimate part of nursing care? A qualitative study.

PloS one·2023

Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients.

Frontiers in aging neuroscience·2022

Memantine Augmentation for Obsessive-Compulsive Symptoms in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

Journal of clinical psychopharmacology·2026

Partial Dopamine Agonists and Gambling Disorder: A Comprehensive Review and Clinical Implications.

Journal of clinical psychopharmacology·2026

Unintentional Lithium Toxicity in Patients With Bipolar Disorder: A Literature Review of Case Reports.

Journal of clinical psychopharmacology·2026

An Open-Label, Randomized, Active Controlled Trial Evaluating Sublingual Dexmedetomidine for Moderate to Severe Agitation in Inpatients With Schizophrenia or Bipolar Disorder.

Journal of clinical psychopharmacology·2026

Comparative Effectiveness of Pharmacogenomics for Treatment of Depression.

Journal of clinical psychopharmacology·2026

Olanzapine/Samidorphan-Associated Opioid Withdrawal Reported to US Poison Centers.

Journal of clinical psychopharmacology·2026

Reduction of CXCR3+CCR6+ CD4+ T Cells and IL-17+ RORγt+ CD4+ T Cells During Secukinumab Treatment Identifies Patients With Axial Spondyloarthritis Responsive to Subsequent Biologic Therapy.

ACR open rheumatology·2026

Longitudinal changes in renal function in rheumatoid arthritis patients treated with biologic agents: a retrospective cohort study.

Clinical rheumatology·2026

Comparison of the Risk of Acute Anterior Uveitis Flare Between Adalimumab and Subcutaneous Infliximab in Patients with Radiographic Axial Spondyloarthritis and Prior Acute Anterior Uveitis: A Randomized Controlled Trial.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026

Distinct spondyloarthritis phenotypes and disease burden in patients with concomitant hidradenitis suppurativa.

Seminars in arthritis and rheumatism·2026

Exploration of reliable assessment of respiratory function in amyotrophic lateral sclerosis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026

A structured primary care-led triage and referral pathway for systemic lupus erythematosus: Operational criteria and referral outcomes from a real-world rheumatology practice.

Lupus·2026

Related Experiment Videos

Bipolar disorder and crossover design

Related Concept Videos

A randomised, double-blind, placebo-controlled crossover trial on cannabinoid-based medication for behavioural disorders in old patients with severe dementia: the study results.

Antiviral Use in Mild-to-Moderate SARS-CoV-2 Infections during the Omicron Wave in Geriatric Patients.

Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol.

Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocol.

Is massage a legitimate part of nursing care? A qualitative study.

Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients.

Memantine Augmentation for Obsessive-Compulsive Symptoms in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

Partial Dopamine Agonists and Gambling Disorder: A Comprehensive Review and Clinical Implications.

Unintentional Lithium Toxicity in Patients With Bipolar Disorder: A Literature Review of Case Reports.

An Open-Label, Randomized, Active Controlled Trial Evaluating Sublingual Dexmedetomidine for Moderate to Severe Agitation in Inpatients With Schizophrenia or Bipolar Disorder.

Comparative Effectiveness of Pharmacogenomics for Treatment of Depression.

Olanzapine/Samidorphan-Associated Opioid Withdrawal Reported to US Poison Centers.

Reduction of CXCR3+CCR6+ CD4+ T Cells and IL-17+ RORγt+ CD4+ T Cells During Secukinumab Treatment Identifies Patients With Axial Spondyloarthritis Responsive to Subsequent Biologic Therapy.

Longitudinal changes in renal function in rheumatoid arthritis patients treated with biologic agents: a retrospective cohort study.

Comparison of the Risk of Acute Anterior Uveitis Flare Between Adalimumab and Subcutaneous Infliximab in Patients with Radiographic Axial Spondyloarthritis and Prior Acute Anterior Uveitis: A Randomized Controlled Trial.

Distinct spondyloarthritis phenotypes and disease burden in patients with concomitant hidradenitis suppurativa.

Exploration of reliable assessment of respiratory function in amyotrophic lateral sclerosis.

A structured primary care-led triage and referral pathway for systemic lupus erythematosus: Operational criteria and referral outcomes from a real-world rheumatology practice.

Related Experiment Videos

Bipolar disorder and crossover design

Related Concept Videos

Related Articles